EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Molecular Drivers of Prostate Cancer Metastasis: Emerging Targets for Precision Therapy

Emeka Eze Joshua Iweala iD, Chukwuemeka Pius Nwokoro iD

Technology in Cancer Research & Treatment · 2026

DOI: 10.1177/15330338251408321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, 2026. Verfasst von Emeka Eze Joshua Iweala und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Nigeria. Hauptthemen laut MEDLINE: Precision Medicine, Prostatic Neoplasms, Molecular Targeted Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Covenant University Center for Research, Innovation, and Discovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) stands as one of the primary cancer diseases affecting male health and represents the principal reason behind death when metastasis develops during late-stage disease. The spread of prostate cancer from its initial site demands intricate molecular interactions through signaling pathways which permit cancer cells to break their attachment to the original tumor mass and form secondary tumor sites in distant organs. Prostate cancer metastasis depends heavily on three main molecular pathways which include the PI3K/AKT signaling cascade along with Wnt/β-catenin pathway and epithelial-mesenchymal transition (EMT) signaling mechanisms. The deregulation of these signaling pathways creates strong contributions toward prostate cancer spread during metastasis and reduction of response to standard treatment methods. Presently available androgen deprivation therapy and chemotherapy have proven successful to some extent yet insufficient for effective treatment of both castration-resistant prostate cancer (CRPC) and metastatic disease. The development of therapies which block AKT signaling combined with Wnt signaling inhibition and reversal of EMT processes creates new treatment opportunities for better cancer outcome results. The combined use of immunotherapy with personalized medicine along with liquid biopsy technologies will improve therapeutic effects by enabling real-time tracking of disease evolution and treatment response. This analysis investigates the molecular processes that drive prostate cancer metastasis and the present therapeutic solutions and the upcoming therapies that try to block these pathways. Numerous treatment approaches and precision medicine strategies combining the integrated treatment approaches may lead to improved therapeutic benefit with fewer adverse effects while delivering more personalized and effective care. This review will majorly focus on the molecular pathways and preclinical treatment options that support metastatic prostate cancer, but briefly outline the clinical progress that is currently shaping the precision therapeutic models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineProstatic NeoplasmsMolecular Targeted TherapyHumansMaleNeoplasm MetastasisEpithelial-Mesenchymal TransitionSignal TransductionWnt Signaling PathwayAnimalsBiomarkers, Tumor

Stichwörter der Autor:innen

PI3K/AKT signaling pathwayWnt/β-catenin pathwayepithelial-mesenchymal transition (EMT)precision oncologyprostate cancer metastasis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Nigeria.
  • Covenant Applied Informatics and Communication Africa Centre of Excellence (CApIC-ACE), Covenant University, Ota, Nigeria.

ORCID-Profile: Emeka Eze Joshua Iweala, Chukwuemeka Pius Nwokoro

Förderung

  • Covenant University Center for Research, Innovation, and Discovery

Zitieren

APA

Iweala, E. E. J., & Nwokoro, C. P. (2026). Molecular Drivers of Prostate Cancer Metastasis: Emerging Targets for Precision Therapy. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251408321

Vancouver

Iweala EEJ, Nwokoro CP. Molecular Drivers of Prostate Cancer Metastasis: Emerging Targets for Precision Therapy. Technology in Cancer Research & Treatment. 2026. doi:10.1177/15330338251408321

BibTeX
@article{Iweala2026,
  author = {Iweala, Emeka Eze Joshua and Nwokoro, Chukwuemeka Pius},
  title = {Molecular Drivers of Prostate Cancer Metastasis: Emerging Targets for Precision Therapy},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  doi = {10.1177/15330338251408321}
}
Kostenlos starten →